Journal Club

Journal of Investigative Dermatology (2008) 128, 1874. doi:10.1038/jid.2008.173

A Paradigm Shift in the Mechanisms of Graft Rejection

For the article: http://dx.doi.org/10.1038/jid.2008.52
For discussion and answers: http://network.nature.com/group/jidclub

Deborah Zell1, Shasa Hu1 and Robert S Kirsner1

1Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA

Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the authorWithout systemic immune suppression, allogeneic transplants are rejected via immunologic mechanisms (Kirsner et al., 1993) thought to involve delayed-type hypersensitivity reactions that are mediated by T cells. Foreign antigens (allograft antigens) are "presented" by antigen-presenting cells (APCs) as they activate T cells in lymph nodes and other secondary lymphoid tissue. Among the highly effective APCs are dendritic cells (DCs), which are thought to be essential to allogeneic graft recognition and rejection. At the time of transplantation, donor DCs are normally included in the transplanted organ or tissue (Lechler and Steinman, 2001). These cells have the capacity to migrate to regional lymph nodes where T-cell activation takes place. Specific to skin are the epidermal DCs, or Langerhans cells (LCs), which likewise are transferred from donor to host with allogeneic skin grafting. Donor LCs are also thought to be important in allogeneic skin graft rejection. The correlation of in vitro studies of LC function from mice to humans is complicated by the fact that LCs display differential effects depending on the environment in which they are studied.

Using a murine model lacking LCs, but retaining a full contingent of other DCs, Obhrai et al. (2008, this issue) tested the hypothesis that LCs are important in mediating allogeneic skin graft rejection. This is one of several mouse models that have previously been used to study LC function. Results from earlier work using this same animal model questioned the traditional role of LCs in delayed hypersensitivity reactions by finding, paradoxically, that contact sensitization is upregulated in the absence of LCs (Kaplan et al., 2005).

By performing genetic mismatched skin grafting experiments in various strains of mice and various types of mismatching using LC-deficient mice as donors, Obhrai et al. (2008) found that LCs were not required for skin graft rejection; grafts from LC-deficient mice were routinely rejected. This finding suggests that, at least in these mice, non-LC DCs probably play a role in skin graft rejection. More surprising was the finding that in a male–female mismatched experiment in which skin grafts are normally accepted (FVB mice), donor skin obtained from LC-deficient donors was rejected. This later finding suggests that LCs inhibit male antigen–associated skin graft rejection in certain strains of mice and warrants further investigation. The reason for this, and the mechanism by which it occurs, remain to be elucidated.

Through the following questions, we examine this paper in greater detail. For brief answers, please refer to http://network.nature.com/group/jidclub.

Top

Questions

  1. What evidence supports the role of LCs in skin graft rejection?
  2. How did the animal model previously developed help in studying contact sensitization and graft rejection?
  3. What were the major findings of this study?
  4. By what mechanisms can LCs from grafts modulate immune response?
  5. What may be the clinical implications of this work?
Top

References

  1. Kaplan DH, Jenison MC, Saeland S, Shlomchik WD, Shlomchik MJ (2005) Epidermal Langerhan cell–deficient mice develop enhanced contact sensitization. Immunity 23 :611–620 | Article | PubMed | ISI | ChemPort |
  2. Kirsner RS, Falanga V, Eaglstein WH (1993) The biology of skin grafts: skin grafts as pharmacologic agents. Arch Dermatol 129 :481–483 | Article | PubMed | ChemPort |
  3. Lechler R, Ng WF, Steinman RM (2001) Dendritic cells in transplantation: friend or foe. Immunity 14:357–368 | Article | PubMed | ISI | ChemPort |
  4. Obhrai JS, Oberbarnscheidt M, Zhang N, Mueller DL, Shlomchik WD, Lakkis FG et al. (2008) Langerhans cells are not required for efficient graft rejection. J Invest Dermatol 128:1950–1955

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

TCR avidity: it's not how strong you make it, it's how you make it strong

Nature Immunology News and Views (01 Aug 2001)

Extra navigation

.
ADVERTISEMENT